| Research Triangle Park Latest News (North Carolina, United States) + Feed Topics Locations Industries Dates
510 views, By CEO Network Powered by Abundant Living Cosulting RALEIGH, NORTH CAROLINA - Abundant Living Consulting Corporation is thrilled to announce the official Grand Opening of an amazing new business in The Raleigh (RTP) area of North Carolina - Pure Serenity.
| ![12953662](data:image/jpeg;base64,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) | 1260 views, By Elixia Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.
| 398 views, By Vivisum Partners, LLC A variety of factors are considered when healthcare providers (HCPs) speak upon which type 2 diabetes treatments in the clinical pipeline may be more disruptive and why.
| 456 views, By Vivisum Partners, LLC Prescribing patterns come from a variety of factors for HCPs, but some are more important than others in the multiple sclerosis marketplace.
| 735 views, By Vivisum Partners, LLC While healthcare providers are more familiar with multiple sclerosis therapies such as Evobrutinib, Ocrevus, and Kesimpta, there is a lot of new buzz and anticipation surrounding new MS drug treatments, according to newly published data by market...
| 432 views, By Vivisum Partners, LLC Among branded ulcerative colitis treatments, 84% of US gastroenterologists expect Zeposia to see an increase in prescription volume over the next 12 months, according to new research on the ulcerative colitis marketplace published by Vivisum Partners.
| 357 views, By Vivisum Partners, LLC New research into ulcerative colitis pipeline drugs found that US gastroenterologists who treat irritable bowel disease (IBD) have low awareness of some developing therapies.
|
Page updated every 30 minutes
| |